Reuters logo
BRIEF-Takeda Initiates Phase 1 Clinical Trial Of Zika Vaccine Candidate
November 28, 2017 / 1:07 PM / in 16 days

BRIEF-Takeda Initiates Phase 1 Clinical Trial Of Zika Vaccine Candidate

Nov 28 (Reuters) - Takeda Pharmaceutical Co Ltd:

* TAKEDA INITIATES PHASE 1 CLINICAL TRIAL OF ZIKA VACCINE CANDIDATE

* SAYS ITS ‍ZIKA VIRUS VACCINE CANDIDATE (TAK-426) HAS PROGRESSED INTO A PHASE 1 CLINICAL TRIAL​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below